edelweiss
Leontopodium nivale
Leontopodium nivale, commonly known as edelweiss, is a traditional Alpine plant with no specific recorded uses in any traditional medicine practices. Scientific research has identified several compounds within this plant, including leoligin, which may have potential as PDE4 inhibitors, though the evidence for its efficacy in this role remains limited and requires further investigation. Additionally, studies have uncovered 551 secondary metabolite biosynthetic gene clusters in Streptomyces strains from Leontopodium nivale subsp. alpinum, suggesting possible antimicrobial activity and the potential discovery of new bioactive compounds. However, no significant effects on tested inflammatory pathways were observed in this research. Safety concerns are currently minimal, with no major issues recorded; similarly, there is no reported evidence of drug interactions.
- Best evidence
- D
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
What the science says
- Six compounds, including leoligin, were identified as potential PDE4 inhibitors, with one analogue, LT-104A, showing comparable activity to known inhibitors.
- The study identified 551 secondary metabolite biosynthetic gene clusters in Streptomyces strains from Leontopodium nivale subsp. alpinum, leading to the discovery of potentially new molecules with antimicrobial activity.
- The study identified 214 secondary metabolite biosynthetic gene clusters in Streptomyces spp. isolated from Leontopodium nivale ssp. alpinum, potentially leading to novel bioactive compounds.
- Leontopodium nivale did not show significant effects on the tested inflammatory pathways in this study.
Frequently asked questions
What is edelweiss?
edelweiss (Leontopodium nivale) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about edelweiss?
4 sourced findings are recorded for edelweiss; the strongest carries evidence grade D. For example: Six compounds, including leoligin, were identified as potential PDE4 inhibitors, with one analogue, LT-104A, showing comparable activity to known inhibitors.
How strong is the evidence for edelweiss?
The strongest finding for edelweiss carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is edelweiss safe? What are the side effects?
No major safety issues are recorded for edelweiss in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does edelweiss interact with medications?
No drug interactions are recorded for edelweiss in our sources. This does not rule them out — check with a pharmacist.
What are the common names of edelweiss?
edelweiss is also known as: Эдельвейс альпийский, edelweiss des Alpes.
Is edelweiss a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 Genomes and secondary metabolomes of Streptomyces spp. isolated from Leontopodium nivale ssp. alpinum. literature abstract metadata
- T2 Selected Plant Extracts Regulating the Inflammatory Immune Response and Oxidative Stress: Focus on Quercus robur. literature abstract metadata
- T2 Secondary Metabolite Biosynthesis Potential of Streptomyces Spp. from the Rhizosphere of Leontopodium nivale Subsp. alpinum. literature abstract metadata
- T2 Identification of a novel PDE4 inhibitor inspired by leoligin-derived lignans. literature abstract metadata